Jong-Il Choi, Songsak Kiatchoosakun, Panyapat Jiampo, Hung Fat Tse, Yannie Oi Yan Soo, Chun-Chieh Wang, Chang Hoon Lee, Ladislav Pecen, Martin Unverdorben, Raffaele De Caterina, Paulus Kirchhof
Background: This study reports prescribing patterns and the 1-year effectiveness and safety of edoxaban in an Asian cohort of Edoxaban Treatment in routiNe clinical prActice (ETNA)-Atrial Fibrillation (AF) patients. Methods and Results: The Global ETNA-AF program integrates prospective, observational, noninterventional regional studies, collecting data on characteristics and clinical outcomes of patients with AF receiving edoxaban for stroke prevention. Baseline characteristics, medical history, and 1-year clinical event rates were assessed in patients from South Korea, Taiwan, Hong Kong, and Thailand...
March 8, 2024: Circulation reports